Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Material Contracts, 2010

EMERGENT BIOSOLUTIONS INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2010-11-05: Form 10-Q; Exhibit 10.8; Description Amendment No. 5 to Product Supply Agreement, dated November 3, 2010, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics, Inc..
  • 2010-11-05: Form 10-Q; Exhibit 10.7; Description Modification No. 7 to Contract No. HHSO100200700037C, dated September 22, 2010, between Emergent BioDefense Operations Lansing Inc. and the Department of Health and Human Services.
  • 2010-11-05: Form 10-Q; Exhibit 10.6; Description Contract No. HHSO100201000059C, dated September 17, 2010, between Emergent Product Development Gaithersburg Inc. and the Department of Health and Human Services.
  • 2010-11-05: Form 10-Q; Exhibit 10.5; Description Modification No. 9 to Contract No. 200-2009-30162, dated July 16, 2010, between Emergent BioDefense Operations Lansing Inc. and the Centers for Disease Control and Prevention.
FiledFormExhibitDescription
2010-11-0510-Q10.8Amendment No. 5 to Product Supply Agreement, dated November 3, 2010, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics, Inc.
2010-11-0510-Q10.7Modification No. 7 to Contract No. HHSO100200700037C, dated September 22, 2010, between Emergent BioDefense Operations Lansing Inc. and the Department of Health and Human Services
2010-11-0510-Q10.6Contract No. HHSO100201000059C, dated September 17, 2010, between Emergent Product Development Gaithersburg Inc. and the Department of Health and Human Services
2010-11-0510-Q10.5Modification No. 9 to Contract No. 200-2009-30162, dated July 16, 2010, between Emergent BioDefense Operations Lansing Inc. and the Centers for Disease Control and Prevention
2010-11-0510-Q10.4Contract No. HHSO100201000034C, dated July 13, 2010, between Emergent BioDefense Operations Lansing Inc. and the Department of Health and Human Services
2010-08-138-K10.3Form of Lock-up Agreement, dated August 12, 2010
2010-08-138-K10.2Form of Support Agreement, dated August 12, 2010
2010-08-138-K10.1Contingent Value Rights Agreement, dated August 12, 2010
2010-08-0610-Q10.4Amended and Restated Board Compensation Program for Outside Directors
2010-08-0610-Q10.3Letter Agreement and Release, dated April 7, 2010, between the Registrant and Denise Esposito
2010-08-0610-Q10.2Consulting Agreement, effective April 7, 2010, between the Registrant and Denise Esposito
2010-05-0610-Q10.1Consulting Services Agreement, effective April 1, 2010, between the Registrant and The Hauer Group (Incorporated by reference to the Registrant’s Current Report on Form 8-K dated April 7, 2010 (File No. 001-33137))
2010-03-0510-K10.41Promissory Note, dated December 30, 2009, from Emergent BioDefense Operations Lansing Inc. to HSBC Realty Credit Corporation (USA)
2010-03-0510-K10.40Loan Agreement, dated December 30, 2009, among the Registrant, Emergent BioDefense Operations Lansing Inc., and HSBC Realty Credit Corporation (USA)
2010-03-0510-K10.26Consulting Services Agreement, effective April 1, 2009, between the Registrant and The Hauer Group
2010-03-0510-K10.22First Addendum to Product Supply Agreement, effective September 1, 2009, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc.
2010-03-0510-K10.21Amendment No. 4 to Product Supply Agreement, effective November 17, 2009, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc.
2010-03-0510-K10.20Amendment No. 3 to Product Supply Agreement, effective August 29, 2007, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc.
2010-03-0510-K10.19Amendment No. 2 to Product Supply Agreement, effective June 25, 2007, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc.
2010-03-0510-K10.18Amendment No. 1 to Product Supply Agreement, effective December 19, 2006, between Emergent Product Development Gaithersburg Inc. and Talecris Biotherapeutics Inc.
2010-03-0510-K10.7Annual Bonus Plan for Executive Officers
2010-03-0510-K10.6Form of Restricted Stock Unit Agreement under Amended and Restated 2006 Stock Incentive Plan

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45